Gujarat Alkalies and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
GUJALKALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GACL's board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025. On a standalone basis, the company swung back to a profit of Rs. 7,344 lakhs for FY25, compared with a loss of Rs. 23,250 lakhs in FY24, with Q4 FY25 profit at Rs. 2,138 lakhs. Standalone revenue from operations rose to Rs. 4,07,291 lakhs from Rs. 3,80,663 lakhs. The board recommended a final dividend of Rs. 15.80 per share (158% on face value of Rs. 10), amounting to Rs. 11,603.03 lakhs in total. M/s Samdani Shah & Kabra was appointed as Secretarial Auditor for five years, and M/s Talati & Talati LLP as Internal Auditor for one year. Shri S J Haider, IAS was appointed as Additional Director, subject to shareholder approval via postal ballot. Consolidated results, however, showed a loss of Rs. 24,510 lakhs, dragged by continued losses at the 60%-owned joint venture GACL-NALCO, which incurred Rs. 13,496 lakhs in losses during the year and accumulated losses of Rs. 59,468 lakhs. The JV also faced a technical disruption at its plant from April 22, 2025.
Positive for shareholders on a standalone basis - the return to profitability and a healthy 158% dividend signal strong operational recovery. However, the persistent and growing losses at the GACL-NALCO joint venture, along with the Rs. 30,000 lakh backstopping commitment on JV debentures and a recent plant shutdown, remain key concerns for consolidated earnings and long-term value.